Document is current
Any future updates will be listed below
-
Authors
Kemp, Bjørn Rørbæk https://orcid.org/0009-0008-0818-1180
Durukan, Emil https://orcid.org/0000-0001-9221-8944
Skaarup, Kristoffer Grundtvig https://orcid.org/0000-0002-2690-7511
Østergren, Peter Busch https://orcid.org/0000-0003-4762-039X
Sønksen, Jens
Fode, Mikkel https://orcid.org/0000-0002-8963-4581
- License Information
-
More Information
Article History
Received: 1 September 2025
Accepted: 16 November 2025
First Online: 27 November 2025
Declarations
:
: KGS served on an advisory board for Sanofi; received financial support for congress participation from AstraZeneca outside the submitted work. PBØ has received honoraria as a speaker and/or consultant from Astellas Pharma, Ipsen, Merck, Accord Healthcare, Pfizer, Bayer, and Johnson & Johnson. None of the engagements have been related to the submitted work. BRK, ED, JS, and MF have no conflicts of interest to declare.
